These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27335385)

  • 1. Live Attenuated Borrelia burgdorferi Targeted Mutants in an Infectious Strain Background Protect Mice from Challenge Infection.
    Hahn BL; Padmore LJ; Ristow LC; Curtis MW; Coburn J
    Clin Vaccine Immunol; 2016 Aug; 23(8):725-31. PubMed ID: 27335385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tick-Tattoo: DNA Vaccination Against
    Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
    Front Immunol; 2021; 12():615011. PubMed ID: 33717102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach to a Lyme disease vaccine.
    Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease.
    Hassan WS; Giaretta PR; Rech R; Ollivault-Shiflett M; Esteve-Gasent MD
    Vaccine; 2019 Sep; 37(37):5596-5606. PubMed ID: 31387750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating BB0405 as a novel Borrelia afzelii vaccination candidate in Lyme borreliosis.
    Klouwens MJ; Trentelman JJ; Ersoz JI; Nieves Marques Porto F; Sima R; Hajdusek O; Thakur M; Pal U; Hovius JW
    Sci Rep; 2021 Feb; 11(1):4775. PubMed ID: 33637813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.
    Batool M; Caoili SEC; Dangott LJ; Gerasimov E; Ionov Y; Piontkivska H; Zelikovsky A; Waghela SD; Rogovskyy AS
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of moderately infectious Borrelia burgdorferi sensu stricto from attenuated cultures by using complement-mediated, antibody-dependent lysis selection technique in a mammalian tissue co-culture system.
    Sen E; Schell RF
    Microbes Infect; 2003 Aug; 5(10):869-78. PubMed ID: 12919855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice.
    Ullmann AJ; Russell TM; Dolan MC; Williams M; Hojgaard A; Weiner ZP; Johnson BJ
    PLoS One; 2015; 10(6):e0128868. PubMed ID: 26076465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of mice with Borrelia burgdorferi lp54 gene encoded recombinant proteins does not provide protection against tick transmitted infectious challenge.
    Brandt KS; Gilmore RD
    Vaccine; 2017 Sep; 35(40):5310-5313. PubMed ID: 28867507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Borrelia burgdorferi BBA64 protein as a protective immunogen in mice.
    Brandt KS; Patton TG; Allard AS; Caimano MJ; Radolf JD; Gilmore RD
    Clin Vaccine Immunol; 2014 Apr; 21(4):526-33. PubMed ID: 24501342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease.
    Bhattacharya D; Bensaci M; Luker KE; Luker G; Wisdom S; Telford SR; Hu LT
    Vaccine; 2011 Oct; 29(44):7818-25. PubMed ID: 21816190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and development of a novel vaccine for protection against Lyme borreliosis.
    Comstedt P; Hanner M; Schüler W; Meinke A; Lundberg U
    PLoS One; 2014; 9(11):e113294. PubMed ID: 25409015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial-infection protocols allow immunodetection of novel Borrelia burgdorferi antigens suitable as vaccine candidates against Lyme disease.
    Wallich R; Jahraus O; Stehle T; Tran TT; Brenner C; Hofmann H; Gern L; Simon MM
    Eur J Immunol; 2003 Mar; 33(3):708-19. PubMed ID: 12616491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with the ospA- and ospB-Negative Borrelia burgdorferi Strain 50772 Provides Significant Protection against Canine Lyme Disease.
    LaFleur RL; Callister SM; Dant JC; Wasmoen TL; Jobe DA; Lovrich SD
    Clin Vaccine Immunol; 2015 Jul; 22(7):836-9. PubMed ID: 25972405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borrelia burgdorferi BBI39 Paralogs, Targets of Protective Immunity, Reduce Pathogen Persistence Either in Hosts or in the Vector.
    Singh P; Verma D; Backstedt BT; Kaur S; Kumar M; Smith AA; Sharma K; Yang X; Azevedo JF; Gomes-Solecki M; Buyuktanir O; Pal U
    J Infect Dis; 2017 Mar; 215(6):1000-1009. PubMed ID: 28453837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reservoir targeted vaccine against Borrelia burgdorferi: a new strategy to prevent Lyme disease transmission.
    Richer LM; Brisson D; Melo R; Ostfeld RS; Zeidner N; Gomes-Solecki M
    J Infect Dis; 2014 Jun; 209(12):1972-80. PubMed ID: 24523510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies.
    Ulbrandt ND; Cassatt DR; Patel NK; Roberts WC; Bachy CM; Fazenbaker CA; Hanson MS
    Infect Immun; 2001 Aug; 69(8):4799-807. PubMed ID: 11447153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice.
    Nardelli DT; Luedtke JO; Munson EL; Warner TF; Callister SM; Schell RF
    FEMS Immunol Med Microbiol; 2010 Oct; 60(1):78-89. PubMed ID: 20662925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines.
    Nassal M; Skamel C; Vogel M; Kratz PA; Stehle T; Wallich R; Simon MM
    Int J Med Microbiol; 2008 Jan; 298(1-2):135-42. PubMed ID: 17888729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.